Qualitix Clinical Research Co., Ltd.   Report issue

For profit Phase 3
Founded: Taipei Taiwan (1997)
Status: Acquired by QPS (2011)

Organization Overview

First Clinical Trial
2009
NCT00997412
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

levofloxacin (levaquin) (1 trial)

tg-873870 (1 trial)

Drugs in Other Trials (2)

azacitidine (vidaza) (1 trial)

mycophenolate (myfortic) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4